Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

The PGE2-EP2-mast cell axis: an antiasthma mechanism.

Torres R, Picado C, de Mora F.

Mol Immunol. 2015 Jan;63(1):61-8. doi: 10.1016/j.molimm.2014.03.007. Epub 2014 Apr 24. Review.

PMID:
24768319
2.

Activation of the Prostaglandin E2 receptor EP2 prevents house dust mite-induced airway hyperresponsiveness and inflammation by restraining mast cells' activity.

Serra-Pages M, Torres R, Plaza J, Herrerias A, Costa-Farré C, Marco A, Jiménez M, Maurer M, Picado C, de Mora F.

Clin Exp Allergy. 2015 Oct;45(10):1590-600. doi: 10.1111/cea.12542.

PMID:
25823713
3.

Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.

Säfholm J, Manson ML, Bood J, Delin I, Orre AC, Bergman P, Al-Ameri M, Dahlén SE, Adner M.

J Allergy Clin Immunol. 2015 Nov;136(5):1232-9.e1. doi: 10.1016/j.jaci.2015.04.002. Epub 2015 May 9.

PMID:
25962903
4.

Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.

Kay LJ, Gilbert M, Pullen N, Skerratt S, Farrington J, Seward EP, Peachell PT.

Clin Exp Allergy. 2013 Jul;43(7):741-51. doi: 10.1111/cea.12142.

PMID:
23786281
5.

Prostaglandin E₂ suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells.

Zasłona Z, Okunishi K, Bourdonnay E, Domingo-Gonzalez R, Moore BB, Lukacs NW, Aronoff DM, Peters-Golden M.

J Allergy Clin Immunol. 2014 Feb;133(2):379-87. doi: 10.1016/j.jaci.2013.07.037. Epub 2013 Sep 24.

6.

Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.

Kay LJ, Yeo WW, Peachell PT.

Br J Pharmacol. 2006 Apr;147(7):707-13.

7.

Prostaglandin E2 prevents hyperosmolar-induced human mast cell activation through prostanoid receptors EP2 and EP4.

Torres-Atencio I, Ainsua-Enrich E, de Mora F, Picado C, Martín M.

PLoS One. 2014 Oct 20;9(10):e110870. doi: 10.1371/journal.pone.0110870. eCollection 2014.

8.

Subcutaneous prostaglandin E(2) restrains airway mast cell activity in vivo and reduces lung eosinophilia and Th(2) cytokine overproduction in house dust mite-sensitive mice.

Herrerias A, Torres R, Serra M, Marco A, Roca-Ferrer J, Picado C, de Mora F.

Int Arch Allergy Immunol. 2009;149(4):323-32. doi: 10.1159/000205578. Epub 2009 Mar 17.

PMID:
19295236
9.
10.

Prostaglandins E2 signal mediated by receptor subtype EP2 promotes IgE production in vivo and contributes to asthma development.

Gao Y, Zhao C, Wang W, Jin R, Li Q, Ge Q, Guan Y, Zhang Y.

Sci Rep. 2016 Feb 8;6:20505. doi: 10.1038/srep20505.

11.

Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes.

Aso H, Ito S, Mori A, Suganuma N, Morioka M, Takahara N, Kondo M, Hasegawa Y.

Am J Respir Cell Mol Biol. 2013 Mar;48(3):322-9. doi: 10.1165/rcmb.2012-0158OC. Epub 2012 Dec 6.

PMID:
23221043
12.

Role of PGE2 in asthma and nonasthmatic eosinophilic bronchitis.

Sastre B, del Pozo V.

Mediators Inflamm. 2012;2012:645383. doi: 10.1155/2012/645383. Epub 2012 Mar 19. Review.

13.

Intravital microscopic studies on acute mast cell-dependent inflammation.

Raud J.

Acta Physiol Scand Suppl. 1989;578:1-58.

PMID:
2471389
14.

Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses.

Feng C, Beller EM, Bagga S, Boyce JA.

Blood. 2006 Apr 15;107(8):3243-50. Epub 2005 Dec 15.

15.

Prostaglandin E2-EP3 signaling induces inflammatory swelling by mast cell activation.

Morimoto K, Shirata N, Taketomi Y, Tsuchiya S, Segi-Nishida E, Inazumi T, Kabashima K, Tanaka S, Murakami M, Narumiya S, Sugimoto Y.

J Immunol. 2014 Feb 1;192(3):1130-7. doi: 10.4049/jimmunol.1300290. Epub 2013 Dec 16.

16.

(S,S)-formoterol increases the production of IL-4 in mast cells and the airways of a murine asthma model.

Abraha D, Cho SH, Agrawal DK, Park JM, Oh CK.

Int Arch Allergy Immunol. 2004 Apr;133(4):380-8. Epub 2004 Mar 17.

PMID:
15031612
17.
18.

CD40 engagement on dendritic cells induces cyclooxygenase-2 and EP2 receptor via p38 and ERK MAPKs.

Harizi H, Limem I, Gualde N.

Immunol Cell Biol. 2011 Feb;89(2):275-82. doi: 10.1038/icb.2010.94. Epub 2010 Aug 10.

PMID:
20697426
20.

Anti-allergic action of anti-malarial drug artesunate in experimental mast cell-mediated anaphylactic models.

Cheng C, Ng DS, Chan TK, Guan SP, Ho WE, Koh AH, Bian JS, Lau HY, Wong WS.

Allergy. 2013 Feb;68(2):195-203. doi: 10.1111/all.12077. Epub 2012 Dec 18.

Supplemental Content

Support Center